Pharmaceutical giants prepare for battle with new corona variant

A number of pharmaceutical companies have started investigating how they can adapt their existing vaccines or design new ones to tackle the new Covid-19 variant, which is spreading rapidly.
Photo: Jeff Pachoud/AFP/Ritzau Scanpix
Photo: Jeff Pachoud/AFP/Ritzau Scanpix
by albert rønning andersson, translated by catherine brett

Researchers all over the world are fighting tooth and nail to identify chinks in the armor of the new coronavirus mutation, called the Omicron variant, which has spread fear throughout the population and the markets over the past few days.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading